Scilex signs binding term sheet for $100M investment from iHolding at $15/share

Scilex Holding Co

iHolding to purchase $100M of newly issued shares at $15/share (~6.67M shares).
Investment subject to due diligence, definitive agreements, board/stockholder approvals, regulatory approvals.
Proceeds to support strategic growth, including product development, acquisitions, working capital.
iHolding is a Kazakhstan-based private investment group; one of largest Kazakhstan-origin healthcare investments into US-listed biopharma.
No assurance of consummation; risks of termination or litigation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.